L1S

Injective gains U.S. regulated futures listing via Bitnomial

Regulated futures tied to Injective’s native token are now live in the United States, trading on Bitnomial, a CFTC-regulated derivatives exchange.

The listing provides institutional investors with compliant access to $INJ exposure through clearing members, with broader availability expected through Bitnomial’s retail platform in the coming weeks. Injective now joins a limited group of digital assets with regulated U.S. futures markets.

The launch may also advance the timeline toward a potential spot ETF, following a filing by Canary Capital with the Cboe.

$INJ is in the top by Netflow across all chains over the past 6 months.

~$234M net inflow.

Right next to $ETH , $SOL , $HYPE, etc.

Given the current market still looks like an accumulation phase, this points to capital flowing in, not out.

More consistent with smart money positioning than distribution.

$INJ to integrate $USDC and cross-chain transfer infrastructure from Circle

Injective is preparing to support USD Coin alongside Circle’s Cross-Chain Transfer Protocol, enabling native movement of $USDC across multiple blockchains.

The integration is expected to expand Injective’s access to stablecoin liquidity and streamline cross-chain trading, capital management and settlement for both users and developers.

The protocol will also support direct interoperability with other networks through CCTP infrastructure.

The rollout is currently live on testnet, with a mainnet launch pending.

$INJ reaches ~630ms block times as performance improves

@Injective is operating with block times of around 630 milliseconds, following ongoing infrastructure optimizations.

The protocol continues to improve execution speed while maintaining reliability, signaling a focus on consistent, low-latency performance as it scales.

$INJ weekly

The key accumulation range sits between 1.1-3.5$, and price is currently trading within it. Historically, completion of this pattern has led to a parabolic expansion phase.

Based on the same structure, the pattern points toward a potential move to ~$100 per INJ, which is also aligned with a long-term ascending resistance formed by ATH peaks across multiple cycles.

From the accumulation range, that implies roughly a 3500% move.

These phases tend to be the least attractive sentiment-wise, but structurally they’ve offered the best positioning.

Injective Sets March 11 Date for Next Community BuyBack 🔥🔥

More than 52,000 $INJ will be allocated in the upcoming round.

The event is scheduled for March 11, 2026.

Participants will be able to earn rewards while $INJ supply continues to be permanently reduced through the burn mechanism

$INJ closed January with ~$19M in network revenue, placing it among the top L1s for the month.

This level of revenue is coming from a relatively lean ecosystem, driven by fee-dense financial activity rather than inflated volume or incentives.

One month doesn’t define a trend, but it’s a clear signal of real economic usage.

BREAKING 🚨

Injective leads all major L1s in 24H chain revenue

Latest data shows $INJ at the top by daily chain revenue, ahead of networks like $SUI , $HYPE , AVAX and ICP.

Revenue reflects actual on-chain usage and fee generation in real time.

When a network consistently tops this metric, it signals where economic activity is currently concentrated.

$INJ entered the top 3 in net capital inflows.

What matters here isn’t the ranking itself, but the persistence across a multi-month window. Short-term rotations can fake momentum. Sustained allocation is harder.

When flows hold at this level, the asset starts being treated as part of the core L1 set rather than an opportunistic trade.

Over the last 365 days, $INJ ranks 2nd among all L1s by code commits.

Real ecosystems grow when engineers keep pushing regardless of market mood.
Injective sitting at the top tier of L1 development activity tells a simple story: the foundation is being reinforced in real time.

$INJ moves to structurally accelerate INJ deflation

Injective has approved IIP-617, introducing changes that permanently increase the rate of INJ supply reduction.

Rather than relying on episodic burns, the update tightens issuance parameters while continuing revenue-backed Community BuyBacks that systematically remove INJ from circulation. The result is a token model where supply contraction becomes an ongoing network behavior, not a cyclical event.

For investors, the shift signals a transition toward a more predictable, structurally deflationary framework, with token supply increasingly tied to real ecosystem activity rather than discretionary policy changes.

$INJ signals accelerated internal expansion.

Injective has significantly increased the pace of its internal development over the past month, according to Mirza, Head of Business Development.

In a recent statement, Mirza pointed to major progress across technology, product development and tokenization initiatives, alongside new business agreements and institutional infrastructure.

He added that these efforts are now converging, positioning Injective for a more advanced phase of execution.

Fast block times only matter if the chain stays predictable under load.

What’s interesting about $INJ isn’t just sub-second blocks, but the fact that performance improvements keep compounding without breaking execution guarantees.

That’s how Web3 infrastructure starts feeling usable, not just fast on paper.

Mirza's account on X

$INJ | Injective
The only chain where I don’t even check the fee before clicking send.

< $0.01 USD

If there’s something faster and cheaper, show me.

Running this long at scale, with deterministic finality and no MEV leakage, is something most chains still struggle to even approximate.

$INJ just treats it as baseline.

$INJ is preparing a series of product launches and strategic initiatives that could make 2026 a pivotal year for the network, according to Mirza, Head of Business Development at @Injective

Speaking about the roadmap currently in development, Mirza said the scale of upcoming plans exceeds anything the Injective has previously delivered, adding that the team is entering a phase he described as “unimaginable.”

Injective just revamped the Exchange Module | $INJ

This actually solves a real execution problem.

On most chains, liquidity is scattered across apps, and everything seems fine until trades get larger. That’s when slippage hits, no matter how good the routing looks.

By consolidating liquidity at the exchange layer, Injective makes execution consistent across dApps instead of forcing each one to patch the same problem individually.

Injective: US Stablecoin Policy Update

$INJ has joined a Blockchain Association policy letter alongside Coinbase and Stripe.

The letter supports core principles of the GENIUS Act, focused on preserving lawful incentive mechanisms and maintaining US leadership in stablecoin innovation.

December’s $INJ Community BuyBack is now full.
Over $250k allocated and filled in record time.

Supply reduction is in progress, while active Injective users earn around 20% from BuyBack.

A clean win-win setup.